Author Details

Name: Joan Genescà

Affiliations: Liver Unit, Digestive Diseases Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research (VHIR), Vall d'Hebron Barcelona Hospital Campus. Universitat Autònoma de Barcelona, Barcelona, Spain.

Publications

• Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial.

• Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.

• Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis.

• Predicting survival in patients with 'non-high-risk' acute variceal bleeding receiving β-blockers+ligation to prevent re-bleeding.

• Alcohol-related liver disease phenotype impacts survival after an acute variceal bleeding episode.

• Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding.

• Bacterial infections in patients with acute variceal bleeding in the era of antibiotic prophylaxis.

• Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS.

• Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.

• Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study.

• Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.